Skip to main content

02.05.2024 | Review

Ductal Stenting in Low-Resource Environments

verfasst von: Navaneetha Sasikumar, Pranoti Toshniwal, Praveen Reddy Bayya, Abish Sudhakar, Raman Krishna Kumar

Erschienen in: Pediatric Cardiology

Einloggen, um Zugang zu erhalten

Abstract

Duct-dependent pulmonary circulation has traditionally been addressed by the Blalock–Taussig–Thomas shunts (BTTS). Recently, catheter-based alternatives such as ductal stenting have emerged as a particularly advantageous option, especially in resource-constrained settings. This article delves into the nuances of ductal stenting within low-resource environments, highlighting its relative ease of application, reduced morbidity, and cost-effectiveness as key factors in its favor. Comparisons in mortality between the two procedures are however likely to be confounded by selection biases. Ductal stenting appears to be particularly beneficial for palliating older infants and children with cyanotic congenital heart disease and diminished pulmonary blood flow who present late. Additionally, it serves as a valuable tool for left ventricular training in late-presenting transposition with an intact ventricular septum. A meticulous pre-procedure echocardiographic assessment of anatomy plays a pivotal role in planning access and hardware, with additional imaging seldom required for this purpose. The adaptation of adult coronary hardware has significantly enhanced the technical feasibility of ductal stenting. However, challenges such as low birth weight and sepsis specifically impact the performance of ductal stenting and patient recovery in low-resource environments. There is potential for systematic application of quality improvement processes to optimize immediate and long-term outcomes of ductal stenting. There is also a need to prospectively examine the application of ductal stenting in low-resource environments through multi-center registries.
Literatur
2.
Zurück zum Zitat Sasikumar N, Hermuzi A, Fan CS, Lee KJ, Chaturvedi R, Hickey E, Honjo O, Van Arsdell GS, Caldarone CA, Agarwal A, Benson L (2017) Outcomes of Blalock–Taussig shunts in current era: a single center experience. Congenital Heart Dis 12(6):808–814. https://doi.org/10.1111/chd.12516CrossRef Sasikumar N, Hermuzi A, Fan CS, Lee KJ, Chaturvedi R, Hickey E, Honjo O, Van Arsdell GS, Caldarone CA, Agarwal A, Benson L (2017) Outcomes of Blalock–Taussig shunts in current era: a single center experience. Congenital Heart Dis 12(6):808–814. https://​doi.​org/​10.​1111/​chd.​12516CrossRef
3.
Zurück zum Zitat Glatz AC, Petit CJ, Goldstein BH, Kelleman MS, McCracken CE, McDonnell A, Buckey T, Mascio CE, Shashidharan S, Ligon RA, Ao J, Whiteside W, Wallen WJ, Metcalf CM, Aggarwal V, Agrawal H, Qureshi AM (2018) Comparison between patent ductus arteriosus stent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterization research collaborative. Circulation 137:589–601. https://doi.org/10.1161/CIRCULATIONAHA.117.029987CrossRefPubMed Glatz AC, Petit CJ, Goldstein BH, Kelleman MS, McCracken CE, McDonnell A, Buckey T, Mascio CE, Shashidharan S, Ligon RA, Ao J, Whiteside W, Wallen WJ, Metcalf CM, Aggarwal V, Agrawal H, Qureshi AM (2018) Comparison between patent ductus arteriosus stent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterization research collaborative. Circulation 137:589–601. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​117.​029987CrossRefPubMed
4.
Zurück zum Zitat Bentham JR, Zava NK, Harrison WJ, Shauq A, Kalantre A, Derrick G, Chen RH, Dhillon R, Taliotis D, Kang S-L, Crossland D, Adesokan A, Hermuzi A, Kudumula V, Yong S, Noonan P, Hayes N, Stumper O, Thomson JDR (2018) Duct stenting versus modified Blalock–Taussig shunt in neonates with duct-dependent pulmonary blood flow: associations with clinical outcomes in a multicenter national study. Circulation 137:581–588. https://doi.org/10.1161/CIRCULATIONAHA.117.028972CrossRefPubMed Bentham JR, Zava NK, Harrison WJ, Shauq A, Kalantre A, Derrick G, Chen RH, Dhillon R, Taliotis D, Kang S-L, Crossland D, Adesokan A, Hermuzi A, Kudumula V, Yong S, Noonan P, Hayes N, Stumper O, Thomson JDR (2018) Duct stenting versus modified Blalock–Taussig shunt in neonates with duct-dependent pulmonary blood flow: associations with clinical outcomes in a multicenter national study. Circulation 137:581–588. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​117.​028972CrossRefPubMed
5.
7.
Zurück zum Zitat Mahesh K, Kannan BR, Vaidyanathan B, Kamath P, Anil SR, Kumar RK (2005) Stenting the patent arterial duct to increase pulmonary blood flow. Indian Heart J 57(6):704–8PubMed Mahesh K, Kannan BR, Vaidyanathan B, Kamath P, Anil SR, Kumar RK (2005) Stenting the patent arterial duct to increase pulmonary blood flow. Indian Heart J 57(6):704–8PubMed
8.
Zurück zum Zitat Pezzella T (2002) Worldwide maldistribution of access to cardiac surgery. J Thorac Cardiovasc Surg 123:1016–1017CrossRefPubMed Pezzella T (2002) Worldwide maldistribution of access to cardiac surgery. J Thorac Cardiovasc Surg 123:1016–1017CrossRefPubMed
9.
Zurück zum Zitat Saxena A (2018) Congenital heart disease in india: a status report. Indian Pediatr 55(12):1075–1082CrossRefPubMed Saxena A (2018) Congenital heart disease in india: a status report. Indian Pediatr 55(12):1075–1082CrossRefPubMed
10.
Zurück zum Zitat Vervoort D, Meuris B, Meyns B, Verbrugghe P (2020) Global cardiac surgery: access to cardiac surgical care around the world. J Thorac Cardiovasc Surg. 159:987-996.e6CrossRefPubMed Vervoort D, Meuris B, Meyns B, Verbrugghe P (2020) Global cardiac surgery: access to cardiac surgical care around the world. J Thorac Cardiovasc Surg. 159:987-996.e6CrossRefPubMed
14.
Zurück zum Zitat Dorobantu DM, Pandey R, Sharabiani MT, Mahani AS, Angelini GD, Martin RP, Stoica SC (2016) In- dications and results of systemic to pulmonary shunts: results from a national database. Eur J Cardiothorac Surg 49:1553–1563CrossRefPubMed Dorobantu DM, Pandey R, Sharabiani MT, Mahani AS, Angelini GD, Martin RP, Stoica SC (2016) In- dications and results of systemic to pulmonary shunts: results from a national database. Eur J Cardiothorac Surg 49:1553–1563CrossRefPubMed
15.
Zurück zum Zitat Bove T, Vandekerckhove K, Panzer J, De Groote K, De Wolf D, François K (2015) Disease-specific outcome analysis of palliation with the modified Blalock–Taussig shunt. World J Pediatr Cong Heart Surg 6:67–74CrossRef Bove T, Vandekerckhove K, Panzer J, De Groote K, De Wolf D, François K (2015) Disease-specific outcome analysis of palliation with the modified Blalock–Taussig shunt. World J Pediatr Cong Heart Surg 6:67–74CrossRef
16.
Zurück zum Zitat Petrucci O, O’Brien SM, Jacobs ML, Jacobs JP, Manning PB, Eghtesady P (2011) Risk factors for mor- tality and morbidity after the neonatal Blalock–Taussig shunt procedure. Ann Thorac Surg 92:642–652CrossRefPubMed Petrucci O, O’Brien SM, Jacobs ML, Jacobs JP, Manning PB, Eghtesady P (2011) Risk factors for mor- tality and morbidity after the neonatal Blalock–Taussig shunt procedure. Ann Thorac Surg 92:642–652CrossRefPubMed
17.
Zurück zum Zitat Dorobantu DM, Pandey R, Sharabiani MT, Mahani AS, Angelini GD, Martin RP, Stoica SC (2016) In- dications and results of systemic to pulmonary shunts: results from a national database. Eur J Cardiothorac Surg 49:1553–1563CrossRefPubMed Dorobantu DM, Pandey R, Sharabiani MT, Mahani AS, Angelini GD, Martin RP, Stoica SC (2016) In- dications and results of systemic to pulmonary shunts: results from a national database. Eur J Cardiothorac Surg 49:1553–1563CrossRefPubMed
18.
Zurück zum Zitat Tseng SY, Truong VT, Peck D, Kandi S, Brayer S, Jason DP 3rd, Mazur W, Hill GD, Ashfaq A, Goldstein BH, Alsaied T (2022) Patent ductus arteriosus stent versus surgical aortopulmonary shunt for initial palliation of cyanotic congenital heart disease with ductal-dependent pulmonary blood flow: a systematic review and meta-analysis. J Am Heart Assoc 11(13):e024721. https://doi.org/10.1161/JAHA.121.024721CrossRefPubMedPubMedCentral Tseng SY, Truong VT, Peck D, Kandi S, Brayer S, Jason DP 3rd, Mazur W, Hill GD, Ashfaq A, Goldstein BH, Alsaied T (2022) Patent ductus arteriosus stent versus surgical aortopulmonary shunt for initial palliation of cyanotic congenital heart disease with ductal-dependent pulmonary blood flow: a systematic review and meta-analysis. J Am Heart Assoc 11(13):e024721. https://​doi.​org/​10.​1161/​JAHA.​121.​024721CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Francis E, Kumar S, Kumar RK (2014) Palliative stenting of patent ductus arteriosus in older children and young adults with congenital cyanotic heart disease. Catheter Cardiovasc Interv 83:1109–1111CrossRefPubMed Francis E, Kumar S, Kumar RK (2014) Palliative stenting of patent ductus arteriosus in older children and young adults with congenital cyanotic heart disease. Catheter Cardiovasc Interv 83:1109–1111CrossRefPubMed
Metadaten
Titel
Ductal Stenting in Low-Resource Environments
verfasst von
Navaneetha Sasikumar
Pranoti Toshniwal
Praveen Reddy Bayya
Abish Sudhakar
Raman Krishna Kumar
Publikationsdatum
02.05.2024
Verlag
Springer US
Erschienen in
Pediatric Cardiology
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-024-03496-8

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.